Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary

Suk Min Seo1, Seonghun Kim, Kiyuk Chang

  • 1Division of Cardiovascular Center and Cardiology, Incheon St. Mary's Hospital, Korea.

Insights

High B-type natriuretic peptide (BNP) levels in ST-segment elevation myocardial infarction (STEMI) patients indicate poor myocardial tissue perfusion after primary percutaneous coronary intervention (PCI). Admission BNP levels can predict perfusion status post-PCI.

Area of Science:

  • Cardiology
  • Biomarkers
  • Myocardial Infarction

Background:

  • Inadequate myocardial tissue perfusion post-revascularization in STEMI correlates with adverse outcomes.
  • Predicting perfusion status is crucial for managing STEMI patients.

Purpose of the Study:

  • To investigate if plasma B-type natriuretic peptide (BNP) levels on admission predict myocardial tissue perfusion after primary PCI in STEMI patients.

Main Methods:

  • 102 STEMI patients undergoing primary PCI within 12 hours of symptom onset were prospectively enrolled.
  • Myocardial tissue perfusion was assessed using ST-segment resolution, corrected thrombolysis in myocardial infarction frame count, and myocardial blush grade.
  • All-cause mortality at 1 month was evaluated.

Main Results:

  • Patients with high BNP (≥80 pg/ml) showed significantly lower ST-segment resolution, higher corrected thrombolysis in myocardial infarction frame count, and lower myocardial blush grade compared to low-BNP (<80 pg/ml) group.
  • High-BNP group exhibited higher short-term mortality (16.2% vs. 3.3%).
  • Low-BNP was an independent predictor of good myocardial tissue perfusion (OR 4.12, P<0.01).

Conclusions:

  • Higher admission BNP levels in STEMI patients are associated with inadequate myocardial tissue perfusion after primary PCI.
  • Plasma BNP levels on admission may serve as a valuable predictor of tissue perfusion post-primary PCI in STEMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...